scholarly journals Capsule endoscopy in inflammatory bowel disease: when and how

2020 ◽  
Vol 18 (3) ◽  
pp. 265-274
Author(s):  
Ida Hilmi ◽  
Taku Kobayashi
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Bowel ◽  
Capsule Endoscopy ◽  
Bowel Disease ◽  
Scoring Systems ◽  
Postoperative Recurrence ◽  
Mucosal Healing ◽  
Cross Sectional ◽  
Inflammatory Bowel ◽  
Capsule Retention

Capsule endoscopy (CE) is emerging as an important investigation in inflammatory bowel disease (IBD); common types include the standard small bowel CE and colon CE. More recently, the pan-enteric CE was developed to assess the large and small bowel in patients with Crohn’s disease (CD). Emerging indications include noninvasive assessment for mucosal healing (both in the small bowel and the colon) and detection of postoperative recurrence in patients with CD. Given the increasing adoption, several CE scoring systems have been specifically developed for IBD. The greatest concern with performing CE, particularly in CD, is capsule retention, but this can be overcome by performing cross-sectional imaging such as magnetic resonance enterography and using patency capsules before performing the procedure. The development of software for automated detection of mucosal abnormalities typically seen in IBD may further increase its adoption.

scholarly journals P410 Which patients with established Crohn’s disease benefit most from the use of the Patency capsule test prior to small bowel capsule endoscopy?

2021 ◽  
Vol 15 (Supplement_1) ◽  
pp. S417-S418
Author(s):  
A Elosua Gonzalez ◽  
M Rullan Iriarte ◽  
S Rubio Iturria ◽  
C Rodríguez Gutiérrez ◽  
M Vicuña Arregui ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Bowel Disease ◽  
Inflammatory Markers ◽  
Postoperative Recurrence ◽  
Mucosal Healing ◽  
Routine Clinical Setting ◽  
Inflammatory Bowel

Abstract Background An important factor that limits a wider utilization of small bowel capsule endoscopy (SBCE) in Crohn’s Disease (CD) is the potential risk of retention. The Patency® capsule (PC) lowers the risk of SBCE retention by assessing pre-procedure intestinal patency. Our aims were to evaluate the use of PC in patients with established CD in routine clinical practice and to identify predictive factors of intestinal patency in CD patients. Methods We included all patients with CD followed in the Inflammatory Bowel Disease Unit of the Complejo Hospitalario de Navarra in which a SBCE was performed from 01/01/2008 to 31/12/2019. An intact PC excreted in its original shape within 30 hours after swallowing was considered a positive patency test. Results A total of 465 SBCE were indicated in 333 patients. In 61.9% a previous patency test with PC was performed, with significant differences in its use according to the age at diagnosis according to the Montreal classification (A1 75.9%, A2 64.8%, A3 46.1%) and behaviour (B2 81.3%, B3 80%, B1 54.2%), the indication (postoperative recurrence monitoring 87.2%, flare 65.5%, staging small bowel disease 52.4%, assessing mucosal healing 44.8%) and the presence of previous CD surgery (68.6% vs. 55.6%). In 33 cases (7%) SBCE was contraindicated due to negative patency test. Eleven SBCE were retained of the 432 procedures finally performed (incidence 2.5%; 95% CI 1.06%-4.02%). Retention occurred in 5.6% of procedures without prior PC compared to 0.4% with previous PC (p<0.001). Stricturing disease (OR 2.94; 1.31-6.58), penetrating disease (OR 3.85; 1.59-9.31) and presence of elevated inflammatory markers (OR 3.73; 1.85-7.50) were identified as independent factors associated with retention (negative PC test or SBCE retention) in the multivariate analysis. Conclusion A patency test prior to SBCE was performed in 61.9% of patients with known CD. The use of PC is associated with a lower risk of SBCE retention in a routine clinical setting. Patients with stricturing or penetrating disease or elevation of inflammatory markers have significantly higher risk of retention and would therefore benefit from a pre-SBCE PC.

scholarly journals P276 A snap-shot review of small bowel capsule endoscopy in the setting of inflammatory bowel disease

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S218-S218
Author(s):  
R. Stack ◽  
L. Ridgeway ◽  
N. Moran ◽  
N. Breslin ◽  
B. Ryan ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Bowel ◽  
Capsule Endoscopy ◽  
Bowel Disease ◽  
Inflammatory Bowel

scholarly journals Inflammatory bowel disease—the role of cross-sectional imaging techniques in the investigation of the small bowel

2014 ◽  
Vol 6 (1) ◽  
pp. 73-83 ◽  
Author(s):  
Athanasios Athanasakos ◽  
Argyro Mazioti ◽  
Nikolaos Economopoulos ◽  
Christina Kontopoulou ◽  
Georgios Stathis ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Bowel ◽  
Bowel Disease ◽  
Imaging Techniques ◽  
Cross Sectional ◽  
Cross Sectional Imaging ◽  
Inflammatory Bowel ◽  
Sectional Imaging

scholarly journals Review: Colon Capsule Endoscopy in Inflammatory Bowel Disease

Diagnostics ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 149
Author(s):  
Writaja Halder ◽  
Faidon-Marios Laskaratos ◽  
Hanan El-Mileik ◽  
Sergio Coda ◽  
Stevan Fox ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Capsule Endoscopy ◽  
Bowel Disease ◽  
Scoring Systems ◽  
Healthcare Services ◽  
Response To Treatment ◽  
Substantial Impact ◽  
Colon Capsule Endoscopy ◽  
Colon Capsule ◽  
Inflammatory Bowel

The COVID-19 pandemic has caused considerable disruption in healthcare services and has had a substantial impact on the care of patients with chronic diseases, such as inflammatory bowel disease. Endoscopy services were significantly restricted, resulting in long waiting lists. There has been a growing interest in the use of capsule endoscopy in the diagnostic pathway and management of these patients. This review explores the published literature on the role of colon capsule endoscopy in ulcerative colitis and Crohn’s disease as a method for mucosal assessment of extent, severity, and response to treatment. Colon capsule preparation regimens and scoring systems are reported. The studies indicate that, despite inherent limitations of minimally invasive capsule endoscopy, there is increasing evidence to support the use of the second-generation colon capsule in inflammatory bowel disease evaluation, providing an additional pathway to expedite investigation of appropriate patients especially during and after the pandemic.

scholarly journals Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support

2018 ◽  
Vol 2018 ◽  
pp. 1-13 ◽  
Author(s):  
Patrick L. Stoner ◽  
Amir Kamel ◽  
Fares Ayoub ◽  
Sanda Tan ◽  
Atif Iqbal ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Bowel ◽  
Bowel Disease ◽  
Nutritional Support ◽  
Nutritional Assessment ◽  
Preoperative Assessment ◽  
Common Finding ◽  
Cross Sectional ◽  
Immunosuppressive Medications ◽  
Inflammatory Bowel

Patients with inflammatory bowel disease (IBD) commonly require surgery despite the availability of an increasingly large repertoire of powerful immunosuppressive medications for the treatment of IBD. Optimizing patients’ care preoperatively is crucial to obtaining good surgical outcomes. This review discusses preoperative assessment and management principles including assessing disease location and activity with cross-sectional or endoscopic imaging, addressing modifiable risk factors (i.e., stopping smoking, weaning steroids, and correcting anemia), and properly managing medications. The major focus of our literature review is the evaluation for malnutrition, a common finding that affects up to 70% of patients with IBD and a well-known, independent risk factor for adverse postoperative outcomes. Our review confirms that whenever feasible, oral or enteral nutrition (EN) is the preferred method of nutritional support; parenteral nutrition (PN) should be reserved for nutritionally deficient IBD patients unable to tolerate EN. In selected patients, recent data demonstrated that the use of preoperative PN resulted in improved nutritional status, fewer postoperative complications, and reduced disease severity. Our review highlights the need for well-designed, prospective trials investigating perioperative nutritional support in patients with IBD. Future studies should perform modern nutritional assessment, standardize for diet, and include patients with UC since this subset of patients is underrepresented in existing studies. In addition, relevant outcome of interest specific to Crohn’s disease (CD) patients such as length of small bowel resected, number of anastomoses, and need for an ostomy should be included as these patients may require repeated small bowel resections.

SMALL-BOWEL CAPSULE ENDOSCOPY IN INFLAMMATORY BOWEL DISEASE TYPE UNCLASSIFIED

2021 ◽  
Vol 160 (3) ◽  
pp. S15
Author(s):  
Ana-Maria Singeap ◽  
Irina Girleanu ◽  
Stefan Chiriac ◽  
Tudor Cuciureanu ◽  
Carol Stanciu ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Small Bowel ◽  
Capsule Endoscopy ◽  
Bowel Disease ◽  
Disease Type ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document